fanta.bio Sample: CNhs11068
26941 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX19538268 | U2OS Bone | 474 / 15264 (3.1%) | 153 / 152640 (0.1%) | −324.0 | −324.0 | 30.98 |
| TP53 SRX19538274 | U2OS Bone | 465 / 15264 (3.0%) | 152 / 152640 (0.1%) | −324.0 | −324.0 | 30.59 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1169 / 15264 (7.7%) | 387 / 152640 (0.3%) | −324.0 | −324.0 | 30.21 |
| HIF1A SRX11007095 | HK-2 Kidney | 2386 / 15264 (15.6%) | 798 / 152640 (0.5%) | −324.0 | −324.0 | 29.90 |
| TP53 SRX19538276 | U2OS Bone | 463 / 15264 (3.0%) | 169 / 152640 (0.1%) | −324.0 | −324.0 | 27.40 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1692 / 15264 (11.1%) | 680 / 152640 (0.4%) | −324.0 | −324.0 | 24.88 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1656 / 15264 (10.8%) | 712 / 152640 (0.5%) | −324.0 | −324.0 | 23.26 |
| HIF1A SRX20663235 | HK-2 Kidney | 540 / 15264 (3.5%) | 240 / 152640 (0.2%) | −324.0 | −324.0 | 22.50 |
| TP53 SRX19538279 | Osteoblasts Bone | 565 / 15264 (3.7%) | 256 / 152640 (0.2%) | −324.0 | −324.0 | 22.07 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2326 / 15264 (15.2%) | 1078 / 152640 (0.7%) | −324.0 | −324.0 | 21.58 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2244 / 15264 (14.7%) | 1059 / 152640 (0.7%) | −324.0 | −324.0 | 21.19 |
| SCML2 SRX644728 | 293 Kidney | 1379 / 15264 (9.0%) | 684 / 152640 (0.4%) | −324.0 | −324.0 | 20.16 |
| MYH11 SRX265221 | ME-1 Blood | 816 / 15264 (5.3%) | 561 / 152640 (0.4%) | −324.0 | −324.0 | 14.55 |
| FOXP1 SRX736067 | LNCAP Prostate | 1599 / 15264 (10.5%) | 1174 / 152640 (0.8%) | −324.0 | −324.0 | 13.62 |
| BRD4 SRX9419935 | BT-474 Breast | 3445 / 15264 (22.6%) | 2625 / 152640 (1.7%) | −324.0 | −324.0 | 13.12 |
| MED1 SRX9419945 | BT-474 Breast | 3362 / 15264 (22.0%) | 2594 / 152640 (1.7%) | −324.0 | −324.0 | 12.96 |
| BRD4 SRX9419937 | BT-474 Breast | 3369 / 15264 (22.1%) | 2639 / 152640 (1.7%) | −324.0 | −324.0 | 12.77 |
| MED1 SRX9419944 | BT-474 Breast | 3273 / 15264 (21.4%) | 2576 / 152640 (1.7%) | −324.0 | −324.0 | 12.71 |
| BRD4 SRX9419936 | BT-474 Breast | 3407 / 15264 (22.3%) | 2744 / 152640 (1.8%) | −324.0 | −324.0 | 12.42 |
| BRD4 SRX9419938 | BT-474 Breast | 3375 / 15264 (22.1%) | 2726 / 152640 (1.8%) | −324.0 | −324.0 | 12.38 |
| MED1 SRX9419946 | BT-474 Breast | 3420 / 15264 (22.4%) | 2767 / 152640 (1.8%) | −324.0 | −324.0 | 12.36 |
| MED1 SRX9419947 | BT-474 Breast | 3286 / 15264 (21.5%) | 2703 / 152640 (1.8%) | −324.0 | −324.0 | 12.16 |
| EZH2 SRX2146136 | LNCAP Prostate | 7207 / 15264 (47.2%) | 7577 / 152640 (5.0%) | −324.0 | −324.0 | 9.51 |
| BRD4 SRX736201 | 90-8TL Neural | 5651 / 15264 (37.0%) | 6074 / 152640 (4.0%) | −324.0 | −324.0 | 9.30 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 717 / 15264 (4.7%) | 804 / 152640 (0.5%) | −324.0 | −324.0 | 8.92 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1698 / 15264 (11.1%) | 2555 / 152640 (1.7%) | −324.0 | −324.0 | 6.65 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1402 / 15264 (9.2%) | 3282 / 152640 (2.2%) | −324.0 | −324.0 | 4.27 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1641 / 15264 (10.8%) | 4519 / 152640 (3.0%) | −324.0 | −324.0 | 3.63 |
| TP53 SRX19538267 | U2OS Bone | 424 / 15264 (2.8%) | 138 / 152640 (0.1%) | −314.8 | −311.7 | 30.72 |
| TP53 SRX19538280 | Osteoblasts Bone | 450 / 15264 (2.9%) | 197 / 152640 (0.1%) | −307.9 | −304.9 | 22.84 |
| TP53 SRX19538275 | U2OS Bone | 418 / 15264 (2.7%) | 155 / 152640 (0.1%) | −300.0 | −296.9 | 26.97 |
| TP53 SRX19538281 | Osteoblasts Bone | 480 / 15264 (3.1%) | 278 / 152640 (0.2%) | −299.2 | −296.2 | 17.27 |
| AGO2 SRX4708039 | Hep G2 Liver | 1892 / 15264 (12.4%) | 6776 / 152640 (4.4%) | −297.8 | −294.7 | 2.79 |
| TP53 SRX19538273 | U2OS Bone | 406 / 15264 (2.7%) | 144 / 152640 (0.1%) | −294.8 | −291.8 | 28.19 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 659 / 15264 (4.3%) | 806 / 152640 (0.5%) | −287.9 | −284.9 | 8.18 |
| IRF3 SRX11453858 | Hep G2 Liver | 344 / 15264 (2.3%) | 67 / 152640 (0.0%) | −284.4 | −281.4 | 51.34 |
| TP53 SRX19538269 | U2OS Bone | 504 / 15264 (3.3%) | 381 / 152640 (0.2%) | −282.3 | −279.4 | 13.23 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 660 / 15264 (4.3%) | 879 / 152640 (0.6%) | −273.1 | −270.2 | 7.51 |
| PBX4 SRX2731658 | PC-3 Prostate | 942 / 15264 (6.2%) | 24015 / 152640 (15.7%) | −266.0 | −263.1 | 0.39 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 404 / 15264 (2.6%) | 211 / 152640 (0.1%) | −261.1 | −258.1 | 19.15 |
| RUNX1 SRX2513054 | 293 Kidney | 3116 / 15264 (20.4%) | 15978 / 152640 (10.5%) | −253.1 | −250.2 | 1.95 |
| TP53 SRX19538270 | U2OS Bone | 464 / 15264 (3.0%) | 376 / 152640 (0.2%) | −251.8 | −248.9 | 12.34 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2071 / 15264 (13.6%) | 8673 / 152640 (5.7%) | −250.6 | −247.8 | 2.39 |
| IRF3 SRX11453861 | Hep G2 Liver | 300 / 15264 (2.0%) | 64 / 152640 (0.0%) | −243.9 | −241.1 | 46.88 |
| TP53 SRX19538282 | Osteoblasts Bone | 420 / 15264 (2.8%) | 292 / 152640 (0.2%) | −243.6 | −240.8 | 14.38 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1407 / 15264 (9.2%) | 4820 / 152640 (3.2%) | −233.1 | −230.3 | 2.92 |
| 5-mC SRX882970 | LNCAP Prostate | 2732 / 15264 (17.9%) | 13660 / 152640 (8.9%) | −232.1 | −229.3 | 2.00 |
| KAT6A SRX20971022 | Fibroblasts Others | 293 / 15264 (1.9%) | 72 / 152640 (0.0%) | −231.7 | −228.9 | 40.69 |
| FOXA1 SRX4815198 | MCF-7 Breast | 887 / 15264 (5.8%) | 21757 / 152640 (14.3%) | −224.3 | −221.4 | 0.41 |
| FOS SRX150477 | MCF 10A Breast | 647 / 15264 (4.2%) | 17960 / 152640 (11.8%) | −217.4 | −214.5 | 0.36 |
| FOS SRX150478 | MCF 10A Breast | 674 / 15264 (4.4%) | 18365 / 152640 (12.0%) | −217.2 | −214.4 | 0.37 |
| TP53 SRX19538271 | U2OS Bone | 639 / 15264 (4.2%) | 1126 / 152640 (0.7%) | −215.6 | −212.8 | 5.67 |
| BRD4 SRX736204 | 90-8TL Neural | 949 / 15264 (6.2%) | 2537 / 152640 (1.7%) | −215.1 | −212.3 | 3.74 |
| 5-mC SRX882968 | LNCAP Prostate | 2661 / 15264 (17.4%) | 13573 / 152640 (8.9%) | −214.4 | −211.6 | 1.96 |
| CIC SRX13262055 | Astrocytes Neural | 2853 / 15264 (18.7%) | 15053 / 152640 (9.9%) | −212.4 | −209.6 | 1.90 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 491 / 15264 (3.2%) | 610 / 152640 (0.4%) | −211.9 | −209.1 | 8.05 |
| FOXA1 SRX4815197 | MCF-7 Breast | 653 / 15264 (4.3%) | 17764 / 152640 (11.6%) | −209.0 | −206.3 | 0.37 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 612 / 15264 (4.0%) | 17027 / 152640 (11.2%) | −205.8 | −203.1 | 0.36 |
| AGO2 SRX6783957 | Hep G2 Liver | 1214 / 15264 (8.0%) | 4090 / 152640 (2.7%) | −204.9 | −202.1 | 2.97 |
| Epitope tags SRX10549776 | K-562 Blood | 1315 / 15264 (8.6%) | 4715 / 152640 (3.1%) | −202.4 | −199.7 | 2.79 |
| AGO2 SRX6783958 | Hep G2 Liver | 1192 / 15264 (7.8%) | 4037 / 152640 (2.6%) | −199.5 | −196.8 | 2.95 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 279 / 15264 (1.8%) | 105 / 152640 (0.1%) | −199.3 | −196.6 | 26.57 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1660 / 15264 (10.9%) | 6948 / 152640 (4.6%) | −197.9 | −195.1 | 2.39 |
| AR SRX10820653 | LNCAP Prostate | 318 / 15264 (2.1%) | 186 / 152640 (0.1%) | −197.3 | −194.6 | 17.10 |
| FOXA1 SRX176862 | MCF-7 Breast | 355 / 15264 (2.3%) | 12522 / 152640 (8.2%) | −194.7 | −192.0 | 0.28 |
| 5-mC SRX882965 | LNCAP Prostate | 2175 / 15264 (14.2%) | 10569 / 152640 (6.9%) | −193.0 | −190.3 | 2.06 |
| FOXA1 SRX176863 | MCF-7 Breast | 325 / 15264 (2.1%) | 11936 / 152640 (7.8%) | −192.4 | −189.7 | 0.27 |
| BRD1 SRX286203 | RKO Digestive tract | 1117 / 15264 (7.3%) | 3723 / 152640 (2.4%) | −190.9 | −188.2 | 3.00 |
| BRPF3 SRX796085 | RKO Digestive tract | 1028 / 15264 (6.7%) | 3251 / 152640 (2.1%) | −188.8 | −186.1 | 3.16 |
| ESR1 SRX7624157 | MCF-7 Breast | 756 / 15264 (5.0%) | 18536 / 152640 (12.1%) | −187.8 | −185.1 | 0.41 |
| ESR1 SRX4367193 | MCF-7 Breast | 955 / 15264 (6.3%) | 21288 / 152640 (13.9%) | −185.8 | −183.1 | 0.45 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 611 / 15264 (4.0%) | 1233 / 152640 (0.8%) | −183.4 | −180.8 | 4.96 |
| FOS SRX4192880 | MCF 10A Breast | 510 / 15264 (3.3%) | 14593 / 152640 (9.6%) | −180.8 | −178.1 | 0.35 |
| KAT7 SRX101303 | RKO Digestive tract | 1243 / 15264 (8.1%) | 4616 / 152640 (3.0%) | −180.4 | −177.8 | 2.69 |
| ESR1 SRX20282961 | MCF-7 Breast | 365 / 15264 (2.4%) | 12232 / 152640 (8.0%) | −180.3 | −177.7 | 0.30 |
| YAP1 SRX757325 | H2052 Lung | 777 / 15264 (5.1%) | 18514 / 152640 (12.1%) | −179.0 | −176.3 | 0.42 |
| TRP47 SRX4548329 | THP-1 Blood | 2398 / 15264 (15.7%) | 12546 / 152640 (8.2%) | −178.5 | −175.9 | 1.91 |
| TP53 SRX396254 | Fibroblasts Others | 852 / 15264 (5.6%) | 2432 / 152640 (1.6%) | −178.1 | −175.4 | 3.50 |
| ESR1 SRX371469 | MCF-7 Breast | 301 / 15264 (2.0%) | 11026 / 152640 (7.2%) | −176.7 | −174.1 | 0.27 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 463 / 15264 (3.0%) | 692 / 152640 (0.5%) | −176.6 | −174.0 | 6.69 |
| GATA3 SRX190239 | MCF-7 Breast | 436 / 15264 (2.9%) | 13268 / 152640 (8.7%) | −176.3 | −173.7 | 0.33 |
| FOXA1 SRX371481 | MCF-7 Breast | 302 / 15264 (2.0%) | 11010 / 152640 (7.2%) | −175.6 | −173.0 | 0.27 |
| FOXA1 SRX3931044 | MCF-7 Breast | 647 / 15264 (4.2%) | 16462 / 152640 (10.8%) | −174.8 | −172.2 | 0.39 |
| FOXA1 SRX1161177 | MCF-7 Breast | 289 / 15264 (1.9%) | 10746 / 152640 (7.0%) | −174.4 | −171.8 | 0.27 |
| FOXA1 SRX371482 | MCF-7 Breast | 428 / 15264 (2.8%) | 13066 / 152640 (8.6%) | −174.1 | −171.5 | 0.33 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1085 / 15264 (7.1%) | 3784 / 152640 (2.5%) | −173.2 | −170.6 | 2.87 |
| SREBF2 SRX5359048 | HCC70 Breast | 1572 / 15264 (10.3%) | 6850 / 152640 (4.5%) | −172.6 | −170.0 | 2.29 |
| ESR1 SRX371478 | MCF-7 Breast | 388 / 15264 (2.5%) | 12351 / 152640 (8.1%) | −172.2 | −169.6 | 0.31 |
| FOXA1 SRX371483 | MCF-7 Breast | 334 / 15264 (2.2%) | 11448 / 152640 (7.5%) | −172.1 | −169.6 | 0.29 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 218 / 15264 (1.4%) | 9389 / 152640 (6.2%) | −171.9 | −169.3 | 0.23 |
| ESR1 SRX7624156 | MCF-7 Breast | 484 / 15264 (3.2%) | 13858 / 152640 (9.1%) | −171.3 | −168.7 | 0.35 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 347 / 15264 (2.3%) | 11631 / 152640 (7.6%) | −170.9 | −168.3 | 0.30 |
| ESR1 SRX371471 | ZR-75-1 Breast | 320 / 15264 (2.1%) | 11162 / 152640 (7.3%) | −170.5 | −168.0 | 0.29 |
| BRPF3 SRX796084 | RKO Digestive tract | 1366 / 15264 (8.9%) | 5556 / 152640 (3.6%) | −169.9 | −167.3 | 2.46 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 607 / 15264 (4.0%) | 1326 / 152640 (0.9%) | −169.2 | −166.6 | 4.58 |
| TP53 SRX19538272 | U2OS Bone | 540 / 15264 (3.5%) | 1049 / 152640 (0.7%) | −167.5 | −165.0 | 5.15 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1748 / 15264 (11.5%) | 8157 / 152640 (5.3%) | −167.2 | −164.6 | 2.14 |
| ESR1 SRX371470 | ZR-75-1 Breast | 269 / 15264 (1.8%) | 10165 / 152640 (6.7%) | −167.1 | −164.5 | 0.26 |
| AR SRX10820651 | LNCAP Prostate | 323 / 15264 (2.1%) | 292 / 152640 (0.2%) | −166.2 | −163.7 | 11.06 |
| YAP1 SRX757326 | H2052 Lung | 678 / 15264 (4.4%) | 16585 / 152640 (10.9%) | −165.7 | −163.1 | 0.41 |
| ESR1 SRX371467 | MCF-7 Breast | 319 / 15264 (2.1%) | 10981 / 152640 (7.2%) | −165.5 | −163.0 | 0.29 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 361 / 15264 (2.4%) | 11682 / 152640 (7.7%) | −165.4 | −162.9 | 0.31 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 765 / 15264 (5.0%) | 2127 / 152640 (1.4%) | −164.8 | −162.3 | 3.60 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1499 / 15264 (9.8%) | 6524 / 152640 (4.3%) | −164.5 | −162.0 | 2.30 |
| FOS SRX150517 | MCF 10A Breast | 542 / 15264 (3.6%) | 14507 / 152640 (9.5%) | −164.3 | −161.8 | 0.37 |
| ESR1 SRX20282960 | MCF-7 Breast | 354 / 15264 (2.3%) | 11509 / 152640 (7.5%) | −163.7 | −161.2 | 0.31 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 685 / 15264 (4.5%) | 16606 / 152640 (10.9%) | −163.5 | −161.0 | 0.41 |
| BRPF3 SRX796086 | RKO Digestive tract | 1305 / 15264 (8.5%) | 5290 / 152640 (3.5%) | −163.0 | −160.5 | 2.47 |
| SSRP1 SRX3436567 | HT-1080 Bone | 390 / 15264 (2.6%) | 512 / 152640 (0.3%) | −162.4 | −159.9 | 7.62 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1658 / 15264 (10.9%) | 7646 / 152640 (5.0%) | −162.1 | −159.6 | 2.17 |
| TLE3 SRX4815191 | MCF-7 Breast | 294 / 15264 (1.9%) | 10444 / 152640 (6.8%) | −162.0 | −159.5 | 0.28 |
| ESR1 SRX371479 | MCF-7 Breast | 285 / 15264 (1.9%) | 10259 / 152640 (6.7%) | −161.2 | −158.7 | 0.28 |
| FOXA1 SRX1161176 | MCF-7 Breast | 294 / 15264 (1.9%) | 10409 / 152640 (6.8%) | −161.0 | −158.5 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 1205 / 15264 (7.9%) | 4714 / 152640 (3.1%) | −159.9 | −157.4 | 2.56 |
| ESR1 SRX176860 | MCF-7 Breast | 525 / 15264 (3.4%) | 14078 / 152640 (9.2%) | −159.5 | −157.0 | 0.37 |
| ESR1 SRX20282939 | MCF-7 Breast | 358 / 15264 (2.3%) | 11435 / 152640 (7.5%) | −159.3 | −156.9 | 0.31 |
| BMI1 SRX7196721 | SF8628 Neural | 1566 / 15264 (10.3%) | 7089 / 152640 (4.6%) | −158.8 | −156.4 | 2.21 |
| RUNX1 SRX2014504 | Jurkat Blood | 2192 / 15264 (14.4%) | 11586 / 152640 (7.6%) | −157.3 | −154.9 | 1.89 |
| ESR1 SRX194569 | MCF-7 Breast | 333 / 15264 (2.2%) | 10943 / 152640 (7.2%) | −157.0 | −154.6 | 0.30 |
| FOS SRX150476 | MCF 10A Breast | 567 / 15264 (3.7%) | 14620 / 152640 (9.6%) | −156.9 | −154.5 | 0.39 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1576 / 15264 (10.3%) | 7198 / 152640 (4.7%) | −156.9 | −154.4 | 2.19 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1745 / 15264 (11.4%) | 8378 / 152640 (5.5%) | −156.3 | −153.9 | 2.08 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 544 / 15264 (3.6%) | 14243 / 152640 (9.3%) | −156.0 | −153.6 | 0.38 |
| FOXA1 SRX1161173 | MCF-7 Breast | 245 / 15264 (1.6%) | 9370 / 152640 (6.1%) | −155.1 | −152.6 | 0.26 |
| MITF SRX1555436 | 501A Epidermis | 1751 / 15264 (11.5%) | 8475 / 152640 (5.6%) | −154.1 | −151.6 | 2.07 |
| STAT5B SRX831881 | CD8+ T cells Blood | 242 / 15264 (1.6%) | 132 / 152640 (0.1%) | −154.0 | −151.6 | 18.33 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 459 / 15264 (3.0%) | 12849 / 152640 (8.4%) | −153.4 | −151.0 | 0.36 |
| JUNB SRX8488088 | SUM 229PE Breast | 641 / 15264 (4.2%) | 15584 / 152640 (10.2%) | −153.3 | −150.9 | 0.41 |
| ESR1 SRX176861 | MCF-7 Breast | 543 / 15264 (3.6%) | 14122 / 152640 (9.3%) | −153.1 | −150.7 | 0.38 |
| MECOM SRX23677885 | HNT-34 Blood | 1586 / 15264 (10.4%) | 7356 / 152640 (4.8%) | −152.7 | −150.3 | 2.16 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1430 / 15264 (9.4%) | 6301 / 152640 (4.1%) | −152.7 | −150.3 | 2.27 |
| MECOM SRX23677896 | HNT-34 Blood | 1906 / 15264 (12.5%) | 9624 / 152640 (6.3%) | −152.2 | −149.8 | 1.98 |
| FOXA1 SRX1161174 | MCF-7 Breast | 323 / 15264 (2.1%) | 10614 / 152640 (7.0%) | −152.1 | −149.7 | 0.30 |
| ESR1 SRX1531791 | MCF-7 Breast | 314 / 15264 (2.1%) | 10465 / 152640 (6.9%) | −152.1 | −149.7 | 0.30 |
| MECOM SRX23677897 | HNT-34 Blood | 1846 / 15264 (12.1%) | 9208 / 152640 (6.0%) | −151.6 | −149.2 | 2.00 |
| ESR1 SRX371468 | MCF-7 Breast | 202 / 15264 (1.3%) | 8473 / 152640 (5.6%) | −151.3 | −149.0 | 0.24 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 418 / 15264 (2.7%) | 12126 / 152640 (7.9%) | −151.2 | −148.9 | 0.34 |
| MECOM SRX23677884 | HNT-34 Blood | 1559 / 15264 (10.2%) | 7203 / 152640 (4.7%) | −151.2 | −148.9 | 2.16 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 477 / 15264 (3.1%) | 13045 / 152640 (8.5%) | −151.1 | −148.8 | 0.37 |
| FOXA1 SRX1161175 | MCF-7 Breast | 236 / 15264 (1.5%) | 9063 / 152640 (5.9%) | −150.4 | −148.0 | 0.26 |
| BMI1 SRX644729 | 293 Kidney | 236 / 15264 (1.5%) | 133 / 152640 (0.1%) | −148.5 | −146.1 | 17.74 |
| FOXA1 SRX100454 | T-47D Breast | 425 / 15264 (2.8%) | 12138 / 152640 (8.0%) | −148.4 | −146.0 | 0.35 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 317 / 15264 (2.1%) | 10353 / 152640 (6.8%) | −147.2 | −144.8 | 0.31 |
| MEAF6 DRX234811 | 293 Kidney | 1482 / 15264 (9.7%) | 6769 / 152640 (4.4%) | −146.9 | −144.5 | 2.19 |
| LEO1 SRX1873456 | SEM Blood | 1289 / 15264 (8.4%) | 5506 / 152640 (3.6%) | −145.6 | −143.3 | 2.34 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1621 / 15264 (10.6%) | 7755 / 152640 (5.1%) | −145.6 | −143.3 | 2.09 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 214 / 15264 (1.4%) | 97 / 152640 (0.1%) | −144.9 | −142.5 | 22.06 |
| ESR1 SRX20282954 | MCF-7 Breast | 368 / 15264 (2.4%) | 11107 / 152640 (7.3%) | −144.8 | −142.4 | 0.33 |
| ESR1 SRX194572 | MCF-7 Breast | 210 / 15264 (1.4%) | 8422 / 152640 (5.5%) | −144.8 | −142.4 | 0.25 |
| AR SRX1067071 | LHSAR Prostate | 674 / 15264 (4.4%) | 15729 / 152640 (10.3%) | −144.7 | −142.3 | 0.43 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 798 / 15264 (5.2%) | 2539 / 152640 (1.7%) | −144.5 | −142.2 | 3.14 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 304 / 15264 (2.0%) | 10045 / 152640 (6.6%) | −144.4 | −142.0 | 0.30 |
| ESR1 SRX371476 | MCF-7 Breast | 251 / 15264 (1.6%) | 9135 / 152640 (6.0%) | −144.4 | −142.0 | 0.27 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1594 / 15264 (10.4%) | 7612 / 152640 (5.0%) | −143.7 | −141.4 | 2.09 |
| ARID1A SRX5089376 | MCF-7 Breast | 283 / 15264 (1.9%) | 9643 / 152640 (6.3%) | −143.0 | −140.7 | 0.29 |
| ESR1 SRX20282972 | MCF-7 Breast | 381 / 15264 (2.5%) | 11239 / 152640 (7.4%) | −142.5 | −140.2 | 0.34 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 435 / 15264 (2.8%) | 12048 / 152640 (7.9%) | −141.4 | −139.1 | 0.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 458 / 15264 (3.0%) | 904 / 152640 (0.6%) | −140.0 | −137.7 | 5.07 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1582 / 15264 (10.4%) | 7614 / 152640 (5.0%) | −140.0 | −137.6 | 2.08 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 560 / 15264 (3.7%) | 13883 / 152640 (9.1%) | −139.8 | −137.5 | 0.40 |
| MEAF6 DRX300417 | 293 Kidney | 1348 / 15264 (8.8%) | 6035 / 152640 (4.0%) | −138.8 | −136.5 | 2.23 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1667 / 15264 (10.9%) | 8251 / 152640 (5.4%) | −138.5 | −136.2 | 2.02 |
| ESR1 SRX20282973 | MCF-7 Breast | 414 / 15264 (2.7%) | 11614 / 152640 (7.6%) | −138.4 | −136.1 | 0.36 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 662 / 15264 (4.3%) | 1885 / 152640 (1.2%) | −138.2 | −135.9 | 3.51 |
| ESR1 SRX20282940 | MCF-7 Breast | 372 / 15264 (2.4%) | 10943 / 152640 (7.2%) | −138.2 | −135.9 | 0.34 |
| FOXA2 SRX3230382 | Hep G2 Liver | 468 / 15264 (3.1%) | 12418 / 152640 (8.1%) | −137.5 | −135.2 | 0.38 |
| FOXA1 SRX371480 | MCF-7 Breast | 229 / 15264 (1.5%) | 8533 / 152640 (5.6%) | −137.5 | −135.2 | 0.27 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 263 / 15264 (1.7%) | 9104 / 152640 (6.0%) | −136.9 | −134.7 | 0.29 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1099 / 15264 (7.2%) | 4450 / 152640 (2.9%) | −136.6 | −134.3 | 2.47 |
| ESR1 SRX10365535 | MCF-7 Breast | 281 / 15264 (1.8%) | 9387 / 152640 (6.1%) | −136.2 | −133.9 | 0.30 |
| GATA3 SRX176864 | MCF-7 Breast | 259 / 15264 (1.7%) | 9007 / 152640 (5.9%) | −135.9 | −133.6 | 0.29 |
| ESR1 SRX4367192 | MCF-7 Breast | 700 / 15264 (4.6%) | 15753 / 152640 (10.3%) | −135.9 | −133.6 | 0.44 |
| FOXA1 SRX100506 | Hep G2 Liver | 460 / 15264 (3.0%) | 12225 / 152640 (8.0%) | −135.6 | −133.3 | 0.38 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1812 / 15264 (11.9%) | 9376 / 152640 (6.1%) | −135.3 | −133.0 | 1.93 |
| ESR1 SRX20282955 | MCF-7 Breast | 368 / 15264 (2.4%) | 10774 / 152640 (7.1%) | −135.1 | −132.8 | 0.34 |
| ESR1 SRX371475 | BT-474 Breast | 164 / 15264 (1.1%) | 7269 / 152640 (4.8%) | −135.0 | −132.7 | 0.23 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 319 / 15264 (2.1%) | 9973 / 152640 (6.5%) | −134.8 | −132.5 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 718 / 15264 (4.7%) | 2222 / 152640 (1.5%) | −134.8 | −132.5 | 3.23 |
| NR2F2 SRX190293 | MCF-7 Breast | 364 / 15264 (2.4%) | 10697 / 152640 (7.0%) | −134.7 | −132.4 | 0.34 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 158 / 15264 (1.0%) | 7144 / 152640 (4.7%) | −134.6 | −132.4 | 0.22 |
| RAC1 SRX10365543 | MCF-7 Breast | 183 / 15264 (1.2%) | 7613 / 152640 (5.0%) | −134.6 | −132.3 | 0.24 |
| CDK9 SRX7366783 | MCF-7 Breast | 221 / 15264 (1.4%) | 137 / 152640 (0.1%) | −134.3 | −132.0 | 16.13 |
| Epitope tags DRX443510 | 293 Kidney | 1265 / 15264 (8.3%) | 5575 / 152640 (3.7%) | −134.2 | −132.0 | 2.27 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 681 / 15264 (4.5%) | 2030 / 152640 (1.3%) | −134.2 | −132.0 | 3.35 |
| ARID1A SRX5089379 | MCF-7 Breast | 339 / 15264 (2.2%) | 10273 / 152640 (6.7%) | −134.1 | −131.8 | 0.33 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 469 / 15264 (3.1%) | 12307 / 152640 (8.1%) | −134.0 | −131.8 | 0.38 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 592 / 15264 (3.9%) | 1578 / 152640 (1.0%) | −133.6 | −131.4 | 3.75 |
| FOS SRX4192879 | MCF 10A Breast | 408 / 15264 (2.7%) | 11344 / 152640 (7.4%) | −133.4 | −131.2 | 0.36 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 484 / 15264 (3.2%) | 1068 / 152640 (0.7%) | −133.4 | −131.1 | 4.53 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 317 / 15264 (2.1%) | 9885 / 152640 (6.5%) | −133.2 | −130.9 | 0.32 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 349 / 15264 (2.3%) | 10381 / 152640 (6.8%) | −132.5 | −130.3 | 0.34 |
| ESR1 SRX2943591 | MCF-7 Breast | 241 / 15264 (1.6%) | 8579 / 152640 (5.6%) | −132.3 | −130.1 | 0.28 |
| FOXA1 SRX11222437 | MCF-7 Breast | 246 / 15264 (1.6%) | 8663 / 152640 (5.7%) | −132.3 | −130.0 | 0.28 |
| ESR1 SRX371477 | MCF-7 Breast | 172 / 15264 (1.1%) | 7323 / 152640 (4.8%) | −131.8 | −129.6 | 0.23 |
| ESR1 SRX20282946 | MCF-7 Breast | 206 / 15264 (1.3%) | 7932 / 152640 (5.2%) | −131.4 | −129.2 | 0.26 |
| FOXA1 SRX11222441 | MCF-7 Breast | 264 / 15264 (1.7%) | 8934 / 152640 (5.9%) | −131.2 | −129.0 | 0.30 |
| FOXA1 SRX3923514 | MCF-7 Breast | 354 / 15264 (2.3%) | 10411 / 152640 (6.8%) | −131.1 | −128.9 | 0.34 |
| FOXA1 SRX1787653 | MCF-7 Breast | 285 / 15264 (1.9%) | 9285 / 152640 (6.1%) | −131.0 | −128.8 | 0.31 |
| TLE3 SRX4815192 | MCF-7 Breast | 317 / 15264 (2.1%) | 9803 / 152640 (6.4%) | −130.8 | −128.6 | 0.32 |
| KMT2A SRX2323891 | 293 Kidney | 862 / 15264 (5.6%) | 3095 / 152640 (2.0%) | −130.7 | −128.5 | 2.79 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 248 / 15264 (1.6%) | 8642 / 152640 (5.7%) | −130.6 | −128.4 | 0.29 |
| AR SRX1067070 | LHSAR Prostate | 870 / 15264 (5.7%) | 17890 / 152640 (11.7%) | −130.6 | −128.4 | 0.49 |
| RAC1 SRX10365541 | MCF-7 Breast | 189 / 15264 (1.2%) | 7594 / 152640 (5.0%) | −130.4 | −128.2 | 0.25 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 278 / 15264 (1.8%) | 9143 / 152640 (6.0%) | −130.4 | −128.2 | 0.30 |
| CDK9 SRX7366781 | MCF-7 Breast | 212 / 15264 (1.4%) | 128 / 152640 (0.1%) | −130.1 | −127.9 | 16.56 |
| ESR1 SRX371474 | BT-474 Breast | 154 / 15264 (1.0%) | 6930 / 152640 (4.5%) | −130.0 | −127.8 | 0.22 |
| ESR1 SRX10365536 | MCF-7 Breast | 192 / 15264 (1.3%) | 7627 / 152640 (5.0%) | −129.6 | −127.4 | 0.25 |
| CEBPB SRX150632 | HeLa Uterus | 813 / 15264 (5.3%) | 17053 / 152640 (11.2%) | −129.2 | −127.0 | 0.48 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 308 / 15264 (2.0%) | 9599 / 152640 (6.3%) | −129.0 | −126.8 | 0.32 |
| MethylCap SRX014766 | NB-4 Blood | 1372 / 15264 (9.0%) | 6414 / 152640 (4.2%) | −128.8 | −126.6 | 2.14 |
| FOXA2 SRX100448 | Hep G2 Liver | 393 / 15264 (2.6%) | 10945 / 152640 (7.2%) | −128.7 | −126.5 | 0.36 |
| ESR1 SRX20282953 | MCF-7 Breast | 290 / 15264 (1.9%) | 9262 / 152640 (6.1%) | −127.8 | −125.7 | 0.31 |
| NFYB SRX16608147 | HeLa Uterus | 230 / 15264 (1.5%) | 177 / 152640 (0.1%) | −127.8 | −125.6 | 12.99 |
| MethylCap SRX014767 | NB-4 Blood | 1504 / 15264 (9.9%) | 7357 / 152640 (4.8%) | −127.7 | −125.5 | 2.04 |
| STAT3 SRX2020842 | HCC70 Breast | 638 / 15264 (4.2%) | 14545 / 152640 (9.5%) | −127.6 | −125.5 | 0.44 |
| FOXA1 SRX3931043 | MCF-7 Breast | 362 / 15264 (2.4%) | 10409 / 152640 (6.8%) | −127.4 | −125.2 | 0.35 |
| TET2 SRX1427029 | 293 Kidney | 1121 / 15264 (7.3%) | 4766 / 152640 (3.1%) | −127.2 | −125.0 | 2.35 |
| ESR1 SRX20282971 | MCF-7 Breast | 355 / 15264 (2.3%) | 10266 / 152640 (6.7%) | −126.5 | −124.3 | 0.35 |
| FOXA1 SRX11222442 | MCF-7 Breast | 232 / 15264 (1.5%) | 8220 / 152640 (5.4%) | −126.1 | −123.9 | 0.28 |
| ESR1 SRX2881000 | MCF-7 Breast | 317 / 15264 (2.1%) | 9636 / 152640 (6.3%) | −125.9 | −123.7 | 0.33 |
| ESR1 SRX3110725 | MCF-7 Breast | 324 / 15264 (2.1%) | 9734 / 152640 (6.4%) | −125.4 | −123.2 | 0.33 |
| Epitope tags SRX10549778 | K-562 Blood | 967 / 15264 (6.3%) | 3819 / 152640 (2.5%) | −125.3 | −123.1 | 2.53 |
| FOXA1 SRX100477 | Hep G2 Liver | 413 / 15264 (2.7%) | 11131 / 152640 (7.3%) | −125.3 | −123.1 | 0.37 |
| ESR1 SRX2881002 | MCF-7 Breast | 343 / 15264 (2.2%) | 10028 / 152640 (6.6%) | −125.1 | −122.9 | 0.34 |
| JUN SRX17561461 | LPS141 Adipocyte | 541 / 15264 (3.5%) | 13017 / 152640 (8.5%) | −124.4 | −122.2 | 0.42 |
| SOX13 SRX2636248 | Hep G2 Liver | 500 / 15264 (3.3%) | 12373 / 152640 (8.1%) | −123.4 | −121.2 | 0.40 |
| RORC SRX5359053 | HCC70 Breast | 1077 / 15264 (7.1%) | 4554 / 152640 (3.0%) | −123.2 | −121.0 | 2.36 |
| AR SRX9469988 | LAPC-4 Prostate | 492 / 15264 (3.2%) | 12242 / 152640 (8.0%) | −123.1 | −120.9 | 0.40 |
| PGR SRX1012655 | MCF-7 Breast | 234 / 15264 (1.5%) | 8144 / 152640 (5.3%) | −122.6 | −120.4 | 0.29 |
| Epitope tags SRX2255894 | 293 Kidney | 1174 / 15264 (7.7%) | 5204 / 152640 (3.4%) | −122.6 | −120.4 | 2.26 |
| FOXA1 SRX028634 | MCF-7 Breast | 177 / 15264 (1.2%) | 7129 / 152640 (4.7%) | −122.5 | −120.4 | 0.25 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 350 / 15264 (2.3%) | 10032 / 152640 (6.6%) | −122.1 | −119.9 | 0.35 |
| JUN SRX4192884 | MCF 10A Breast | 318 / 15264 (2.1%) | 9522 / 152640 (6.2%) | −122.0 | −119.9 | 0.33 |
| GATA3 SRX5057632 | MCF-7 Breast | 248 / 15264 (1.6%) | 8359 / 152640 (5.5%) | −122.0 | −119.8 | 0.30 |
| ERG SRX063922 | K-562 Blood | 1339 / 15264 (8.8%) | 6343 / 152640 (4.2%) | −121.9 | −119.7 | 2.11 |
| FOXA1 SRX3931055 | MCF-7 Breast | 311 / 15264 (2.0%) | 9397 / 152640 (6.2%) | −121.7 | −119.6 | 0.33 |
| ESR1 SRX10365532 | MCF-7 Breast | 204 / 15264 (1.3%) | 7590 / 152640 (5.0%) | −121.6 | −119.5 | 0.27 |
| FOXA1 SRX3931054 | MCF-7 Breast | 345 / 15264 (2.3%) | 9938 / 152640 (6.5%) | −121.6 | −119.4 | 0.35 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 410 / 15264 (2.7%) | 10930 / 152640 (7.2%) | −121.1 | −118.9 | 0.38 |
| ESR1 SRX4451213 | MCF-7 Breast | 382 / 15264 (2.5%) | 10498 / 152640 (6.9%) | −121.0 | −118.9 | 0.36 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 471 / 15264 (3.1%) | 11848 / 152640 (7.8%) | −120.9 | −118.8 | 0.40 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 354 / 15264 (2.3%) | 10049 / 152640 (6.6%) | −120.8 | −118.6 | 0.35 |
| GRHL3 SRX2582162 | NHEK Epidermis | 910 / 15264 (6.0%) | 3544 / 152640 (2.3%) | −120.6 | −118.5 | 2.57 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 343 / 15264 (2.2%) | 9869 / 152640 (6.5%) | −120.5 | −118.4 | 0.35 |
| ESR1 SRX8537722 | MCF-7 Breast | 344 / 15264 (2.3%) | 9878 / 152640 (6.5%) | −120.4 | −118.3 | 0.35 |
| FOXA1 SRX1447317 | MCF-7 Breast | 237 / 15264 (1.6%) | 8121 / 152640 (5.3%) | −120.4 | −118.2 | 0.29 |
| SSRP1 SRX3436566 | HT-1080 Bone | 278 / 15264 (1.8%) | 344 / 152640 (0.2%) | −120.2 | −118.1 | 8.08 |
| AR SRX9109110 | MDA-MB-453 Breast | 683 / 15264 (4.5%) | 14879 / 152640 (9.7%) | −120.2 | −118.0 | 0.46 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 363 / 15264 (2.4%) | 10165 / 152640 (6.7%) | −120.1 | −118.0 | 0.36 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 179 / 15264 (1.2%) | 84 / 152640 (0.1%) | −120.0 | −117.8 | 21.31 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 184 / 15264 (1.2%) | 94 / 152640 (0.1%) | −119.9 | −117.8 | 19.57 |
| FOXA1 SRX6878603 | LNCAP Prostate | 405 / 15264 (2.7%) | 10811 / 152640 (7.1%) | −119.9 | −117.7 | 0.37 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 335 / 15264 (2.2%) | 9714 / 152640 (6.4%) | −119.8 | −117.6 | 0.34 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 399 / 15264 (2.6%) | 10707 / 152640 (7.0%) | −119.6 | −117.4 | 0.37 |
| ESR1 SRX10365533 | MCF-7 Breast | 177 / 15264 (1.2%) | 7035 / 152640 (4.6%) | −119.4 | −117.3 | 0.25 |
| ERG SRX063921 | K-562 Blood | 1271 / 15264 (8.3%) | 5932 / 152640 (3.9%) | −119.3 | −117.2 | 2.14 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1326 / 15264 (8.7%) | 6311 / 152640 (4.1%) | −119.3 | −117.2 | 2.10 |
| GATAD2A SRX2636506 | Hep G2 Liver | 482 / 15264 (3.2%) | 11950 / 152640 (7.8%) | −119.2 | −117.1 | 0.40 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 338 / 15264 (2.2%) | 9721 / 152640 (6.4%) | −118.7 | −116.6 | 0.35 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 654 / 15264 (4.3%) | 14405 / 152640 (9.4%) | −118.6 | −116.5 | 0.45 |
| FOXA1 SRX1161203 | T-47D Breast | 267 / 15264 (1.7%) | 8565 / 152640 (5.6%) | −118.5 | −116.4 | 0.31 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 352 / 15264 (2.3%) | 9931 / 152640 (6.5%) | −118.4 | −116.3 | 0.35 |
| CEBPA SRX2630241 | Hep G2 Liver | 460 / 15264 (3.0%) | 11588 / 152640 (7.6%) | −118.3 | −116.2 | 0.40 |
| MECOM SRX23677890 | HNT-34 Blood | 1527 / 15264 (10.0%) | 7765 / 152640 (5.1%) | −117.9 | −115.8 | 1.97 |
| TEAD1 SRX3401272 | MCF-7 Breast | 290 / 15264 (1.9%) | 8926 / 152640 (5.8%) | −117.9 | −115.8 | 0.32 |
| ESR1 SRX5323873 | MCF-7 Breast | 463 / 15264 (3.0%) | 11610 / 152640 (7.6%) | −117.8 | −115.7 | 0.40 |
| RORC SRX5359052 | HCC70 Breast | 1094 / 15264 (7.2%) | 4773 / 152640 (3.1%) | −117.8 | −115.7 | 2.29 |
| FOXA1 SRX11222438 | MCF-7 Breast | 197 / 15264 (1.3%) | 7337 / 152640 (4.8%) | −117.7 | −115.6 | 0.27 |
| ZFX SRX7805372 | 293 Kidney | 1319 / 15264 (8.6%) | 6310 / 152640 (4.1%) | −117.3 | −115.2 | 2.09 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1404 / 15264 (9.2%) | 6912 / 152640 (4.5%) | −117.0 | −114.9 | 2.03 |
| JUNB SRX8488089 | SUM 229PE Breast | 388 / 15264 (2.5%) | 10441 / 152640 (6.8%) | −116.9 | −114.8 | 0.37 |
| GATA3 SRX6712581 | MCF-7 Breast | 310 / 15264 (2.0%) | 9207 / 152640 (6.0%) | −116.7 | −114.6 | 0.34 |
| NABP2 SRX9523535 | HT-1080 Bone | 1160 / 15264 (7.6%) | 5235 / 152640 (3.4%) | −116.7 | −114.6 | 2.22 |
| ESR1 SRX330067 | MCF-7 Breast | 348 / 15264 (2.3%) | 9797 / 152640 (6.4%) | −116.4 | −114.3 | 0.36 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 365 / 15264 (2.4%) | 10060 / 152640 (6.6%) | −116.3 | −114.2 | 0.36 |
| ESR1 SRX20282938 | MCF-7 Breast | 307 / 15264 (2.0%) | 9141 / 152640 (6.0%) | −116.2 | −114.1 | 0.34 |
| EP300 SRX1012648 | MCF-7 Breast | 183 / 15264 (1.2%) | 7036 / 152640 (4.6%) | −116.0 | −113.9 | 0.26 |
| GATA3 SRX5457550 | MCF-7 Breast | 438 / 15264 (2.9%) | 11161 / 152640 (7.3%) | −115.9 | −113.8 | 0.39 |
| FOXA1 SRX028635 | MCF-7 Breast | 189 / 15264 (1.2%) | 7134 / 152640 (4.7%) | −115.8 | −113.7 | 0.26 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 266 / 15264 (1.7%) | 8454 / 152640 (5.5%) | −115.8 | −113.7 | 0.31 |
| CEBPB SRX190345 | MCF-7 Breast | 299 / 15264 (2.0%) | 8996 / 152640 (5.9%) | −115.8 | −113.7 | 0.33 |
| ARID1A SRX5089385 | MCF-7 Breast | 282 / 15264 (1.8%) | 8716 / 152640 (5.7%) | −115.7 | −113.7 | 0.32 |
| ESR1 SRX1531796 | MCF-7 Breast | 205 / 15264 (1.3%) | 7412 / 152640 (4.9%) | −115.6 | −113.5 | 0.28 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1136 / 15264 (7.4%) | 5096 / 152640 (3.3%) | −115.5 | −113.5 | 2.23 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 406 / 15264 (2.7%) | 10664 / 152640 (7.0%) | −115.5 | −113.4 | 0.38 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 963 / 15264 (6.3%) | 18452 / 152640 (12.1%) | −115.2 | −113.1 | 0.52 |
| ARID5B SRX10475139 | Hep G2 Liver | 417 / 15264 (2.7%) | 10801 / 152640 (7.1%) | −114.7 | −112.6 | 0.39 |
| FOXA1 SRX1961158 | T-47D Breast | 375 / 15264 (2.5%) | 10152 / 152640 (6.7%) | −114.5 | −112.4 | 0.37 |
| ESR1 SRX330070 | MCF-7 Breast | 199 / 15264 (1.3%) | 7270 / 152640 (4.8%) | −114.4 | −112.3 | 0.27 |
| ESR1 SRX1012632 | MCF-7 Breast | 192 / 15264 (1.3%) | 7143 / 152640 (4.7%) | −114.3 | −112.3 | 0.27 |
| FOXA1 SRX3923517 | MCF-7 Breast | 272 / 15264 (1.8%) | 8498 / 152640 (5.6%) | −114.2 | −112.1 | 0.32 |
| FOXA1 SRX1961157 | T-47D Breast | 411 / 15264 (2.7%) | 10689 / 152640 (7.0%) | −114.1 | −112.1 | 0.38 |
| JUNB SRX10119386 | MCF 10A Breast | 356 / 15264 (2.3%) | 9841 / 152640 (6.4%) | −114.0 | −112.0 | 0.36 |
| CXXC1 SRX1424886 | SEM Blood | 1210 / 15264 (7.9%) | 5635 / 152640 (3.7%) | −113.9 | −111.9 | 2.15 |
| FOXA1 SRX1787652 | MCF-7 Breast | 235 / 15264 (1.5%) | 7871 / 152640 (5.2%) | −113.8 | −111.8 | 0.30 |
| FOXA1 SRX3923516 | MCF-7 Breast | 275 / 15264 (1.8%) | 8531 / 152640 (5.6%) | −113.7 | −111.6 | 0.32 |
| ESR1 SRX20282959 | MCF-7 Breast | 161 / 15264 (1.1%) | 6561 / 152640 (4.3%) | −113.6 | −111.5 | 0.25 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 358 / 15264 (2.3%) | 9851 / 152640 (6.5%) | −113.5 | −111.5 | 0.36 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 907 / 15264 (5.9%) | 3648 / 152640 (2.4%) | −113.4 | −111.4 | 2.49 |
| NR3C1 SRX17639412 | A549 Lung | 435 / 15264 (2.8%) | 11027 / 152640 (7.2%) | −113.4 | −111.4 | 0.39 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 477 / 15264 (3.1%) | 1213 / 152640 (0.8%) | −113.4 | −111.4 | 3.93 |
| AR SRX9109113 | MDA-MB-453 Breast | 712 / 15264 (4.7%) | 14992 / 152640 (9.8%) | −113.3 | −111.3 | 0.47 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 190 / 15264 (1.2%) | 7074 / 152640 (4.6%) | −113.3 | −111.2 | 0.27 |
| ESR1 SRX330069 | MCF-7 Breast | 240 / 15264 (1.6%) | 7934 / 152640 (5.2%) | −113.1 | −111.1 | 0.30 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 910 / 15264 (6.0%) | 17655 / 152640 (11.6%) | −113.1 | −111.1 | 0.52 |
| ESR1 SRX4451212 | MCF-7 Breast | 373 / 15264 (2.4%) | 10069 / 152640 (6.6%) | −113.0 | −111.0 | 0.37 |
| ESR1 SRX10365558 | MCF-7 Breast | 267 / 15264 (1.7%) | 8372 / 152640 (5.5%) | −112.9 | −110.8 | 0.32 |
| TET2 SRX2014505 | Jurkat Blood | 2215 / 15264 (14.5%) | 13121 / 152640 (8.6%) | −112.8 | −110.8 | 1.69 |
| GRHL3 SRX2582161 | NHEK Epidermis | 753 / 15264 (4.9%) | 2722 / 152640 (1.8%) | −112.7 | −110.6 | 2.77 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1241 / 15264 (8.1%) | 21916 / 152640 (14.4%) | −112.6 | −110.6 | 0.57 |
| ESR1 SRX5323878 | MCF-7 Breast | 388 / 15264 (2.5%) | 10282 / 152640 (6.7%) | −112.6 | −110.6 | 0.38 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1318 / 15264 (8.6%) | 22868 / 152640 (15.0%) | −112.3 | −110.3 | 0.58 |
| EP300 SRX176885 | MCF-7 Breast | 204 / 15264 (1.3%) | 7275 / 152640 (4.8%) | −111.9 | −109.9 | 0.28 |
| ESR1 SRX8537723 | MCF-7 Breast | 316 / 15264 (2.1%) | 9126 / 152640 (6.0%) | −111.7 | −109.7 | 0.35 |
| ESR1 SRX5323871 | MCF-7 Breast | 426 / 15264 (2.8%) | 10820 / 152640 (7.1%) | −111.5 | −109.5 | 0.39 |
| MECOM SRX23677891 | HNT-34 Blood | 1502 / 15264 (9.8%) | 7754 / 152640 (5.1%) | −111.5 | −109.4 | 1.94 |
| FOXA1 SRX5323843 | MCF-7 Breast | 202 / 15264 (1.3%) | 7226 / 152640 (4.7%) | −111.4 | −109.4 | 0.28 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1100 / 15264 (7.2%) | 20046 / 152640 (13.1%) | −111.2 | −109.2 | 0.55 |
| ESR1 SRX2943589 | MCF-7 Breast | 204 / 15264 (1.3%) | 7251 / 152640 (4.8%) | −111.2 | −109.2 | 0.28 |
| Epitope tags SRX2867680 | 293 Kidney | 1740 / 15264 (11.4%) | 9522 / 152640 (6.2%) | −111.0 | −109.0 | 1.83 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 885 / 15264 (5.8%) | 17229 / 152640 (11.3%) | −110.9 | −108.9 | 0.51 |
| PROX1 SRX3230397 | Hep G2 Liver | 289 / 15264 (1.9%) | 8665 / 152640 (5.7%) | −110.9 | −108.9 | 0.33 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1185 / 15264 (7.8%) | 5533 / 152640 (3.6%) | −110.7 | −108.7 | 2.14 |
| YAP1 SRX5718140 | 293 Kidney | 671 / 15264 (4.4%) | 14317 / 152640 (9.4%) | −110.7 | −108.7 | 0.47 |
| ARID5B SRX3230377 | Hep G2 Liver | 935 / 15264 (6.1%) | 17879 / 152640 (11.7%) | −110.7 | −108.7 | 0.52 |
| ESR1 SRX1469949 | MCF-7 Breast | 226 / 15264 (1.5%) | 7612 / 152640 (5.0%) | −110.6 | −108.6 | 0.30 |
| ESR1 SRX1012629 | MCF-7 Breast | 250 / 15264 (1.6%) | 8011 / 152640 (5.2%) | −110.5 | −108.5 | 0.31 |
| GATA3 SRX190194 | SK-N-SH Neural | 899 / 15264 (5.9%) | 17383 / 152640 (11.4%) | −110.3 | −108.3 | 0.52 |
| ARID1A SRX5089382 | MCF-7 Breast | 276 / 15264 (1.8%) | 8430 / 152640 (5.5%) | −110.3 | −108.3 | 0.33 |
| ING2 SRX286201 | RKO Digestive tract | 1174 / 15264 (7.7%) | 5467 / 152640 (3.6%) | −110.3 | −108.3 | 2.15 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 566 / 15264 (3.7%) | 12811 / 152640 (8.4%) | −110.0 | −108.0 | 0.44 |
| FOXA1 SRX1787655 | MCF-7 Breast | 200 / 15264 (1.3%) | 7143 / 152640 (4.7%) | −109.9 | −107.9 | 0.28 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 369 / 15264 (2.4%) | 9888 / 152640 (6.5%) | −109.8 | −107.8 | 0.37 |
| FOXA1 SRX15430999 | T-47D Breast | 434 / 15264 (2.8%) | 10859 / 152640 (7.1%) | −109.4 | −107.4 | 0.40 |
| JUNB SRX4192882 | MCF 10A Breast | 323 / 15264 (2.1%) | 9152 / 152640 (6.0%) | −109.3 | −107.3 | 0.35 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 407 / 15264 (2.7%) | 10446 / 152640 (6.8%) | −109.2 | −107.2 | 0.39 |
| CEBPA SRX4705113 | MOLM-13 Blood | 880 / 15264 (5.8%) | 17074 / 152640 (11.2%) | −109.1 | −107.1 | 0.52 |
| ESR1 SRX3123829 | MCF-7 Breast | 232 / 15264 (1.5%) | 7659 / 152640 (5.0%) | −109.1 | −107.1 | 0.30 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 759 / 15264 (5.0%) | 15446 / 152640 (10.1%) | −108.9 | −106.9 | 0.49 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 158 / 15264 (1.0%) | 6342 / 152640 (4.2%) | −108.4 | −106.4 | 0.25 |
| SOX5 SRX2636544 | Hep G2 Liver | 394 / 15264 (2.6%) | 10217 / 152640 (6.7%) | −108.3 | −106.3 | 0.39 |
| EP300 SRX1012644 | MCF-7 Breast | 184 / 15264 (1.2%) | 6797 / 152640 (4.5%) | −108.0 | −106.0 | 0.27 |
| FOXA1 SRX1787651 | MCF-7 Breast | 229 / 15264 (1.5%) | 7572 / 152640 (5.0%) | −107.9 | −105.9 | 0.30 |
| NANOG SRX10445309 | Neural crest cells Neural | 215 / 15264 (1.4%) | 7329 / 152640 (4.8%) | −107.8 | −105.8 | 0.29 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1248 / 15264 (8.2%) | 21760 / 152640 (14.3%) | −107.8 | −105.8 | 0.57 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 762 / 15264 (5.0%) | 15425 / 152640 (10.1%) | −107.6 | −105.6 | 0.49 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1588 / 15264 (10.4%) | 8490 / 152640 (5.6%) | −107.5 | −105.6 | 1.87 |
| ARID1A SRX5089391 | MCF-7 Breast | 228 / 15264 (1.5%) | 7542 / 152640 (4.9%) | −107.5 | −105.5 | 0.30 |
| AR SRX1067066 | LHSAR Prostate | 814 / 15264 (5.3%) | 16123 / 152640 (10.6%) | −107.5 | −105.5 | 0.50 |
| FOXA1 SRX5323829 | T-47D Breast | 225 / 15264 (1.5%) | 7484 / 152640 (4.9%) | −107.3 | −105.3 | 0.30 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 152 / 15264 (1.0%) | 6200 / 152640 (4.1%) | −107.3 | −105.3 | 0.25 |
| FOXA1 SRX9604647 | LNCAP Prostate | 589 / 15264 (3.9%) | 13027 / 152640 (8.5%) | −107.3 | −105.3 | 0.45 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 555 / 15264 (3.6%) | 1679 / 152640 (1.1%) | −107.1 | −105.1 | 3.31 |
| FOXA2 SRX10475773 | Hep G2 Liver | 485 / 15264 (3.2%) | 11520 / 152640 (7.5%) | −107.0 | −105.1 | 0.42 |
| AR SRX1067067 | LHSAR Prostate | 680 / 15264 (4.5%) | 14278 / 152640 (9.4%) | −107.0 | −105.0 | 0.48 |
| ESR1 SRX792933 | LY2 Breast | 330 / 15264 (2.2%) | 9166 / 152640 (6.0%) | −106.7 | −104.7 | 0.36 |
| SMARCA2 SRX8119677 | MeT-5A Others | 652 / 15264 (4.3%) | 13877 / 152640 (9.1%) | −106.6 | −104.6 | 0.47 |
| ESR1 SRX1012633 | MCF-7 Breast | 212 / 15264 (1.4%) | 7234 / 152640 (4.7%) | −106.5 | −104.5 | 0.29 |
| FOXA1 SRX3923518 | MCF-7 Breast | 276 / 15264 (1.8%) | 8298 / 152640 (5.4%) | −106.3 | −104.4 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 345 / 15264 (2.3%) | 9387 / 152640 (6.1%) | −106.3 | −104.3 | 0.37 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 881 / 15264 (5.8%) | 16960 / 152640 (11.1%) | −106.2 | −104.2 | 0.52 |
| EP300 SRX176883 | MCF-7 Breast | 194 / 15264 (1.3%) | 6911 / 152640 (4.5%) | −106.1 | −104.1 | 0.28 |
| HMG20A SRX2630163 | Hep G2 Liver | 235 / 15264 (1.5%) | 7612 / 152640 (5.0%) | −106.1 | −104.1 | 0.31 |
| GATAD2A SRX2636507 | Hep G2 Liver | 436 / 15264 (2.9%) | 10758 / 152640 (7.0%) | −106.0 | −104.1 | 0.41 |
| ESR1 SRX5323872 | MCF-7 Breast | 403 / 15264 (2.6%) | 10261 / 152640 (6.7%) | −105.9 | −103.9 | 0.39 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 330 / 15264 (2.2%) | 9138 / 152640 (6.0%) | −105.9 | −103.9 | 0.36 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 268 / 15264 (1.8%) | 8148 / 152640 (5.3%) | −105.8 | −103.8 | 0.33 |
| GATA3 SRX100559 | T-47D Breast | 446 / 15264 (2.9%) | 10896 / 152640 (7.1%) | −105.7 | −103.8 | 0.41 |
| FOXA1 SRX1447316 | MCF-7 Breast | 170 / 15264 (1.1%) | 6475 / 152640 (4.2%) | −105.7 | −103.8 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 271 / 15264 (1.8%) | 8189 / 152640 (5.4%) | −105.6 | −103.7 | 0.33 |
| FOXA1 SRX219284 | LNCAP Prostate | 531 / 15264 (3.5%) | 12127 / 152640 (7.9%) | −105.6 | −103.6 | 0.44 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 352 / 15264 (2.3%) | 9465 / 152640 (6.2%) | −105.4 | −103.5 | 0.37 |
| JUNB SRX8488073 | SUM 229PE Breast | 751 / 15264 (4.9%) | 15185 / 152640 (9.9%) | −105.4 | −103.5 | 0.49 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 173 / 15264 (1.1%) | 6516 / 152640 (4.3%) | −105.3 | −103.3 | 0.27 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 312 / 15264 (2.0%) | 8835 / 152640 (5.8%) | −105.3 | −103.3 | 0.35 |
| JADE3 DRX300415 | 293 Kidney | 1242 / 15264 (8.1%) | 6058 / 152640 (4.0%) | −105.1 | −103.2 | 2.05 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1432 / 15264 (9.4%) | 23915 / 152640 (15.7%) | −105.1 | −103.2 | 0.60 |
| ARID1A SRX5089388 | MCF-7 Breast | 213 / 15264 (1.4%) | 7201 / 152640 (4.7%) | −104.9 | −103.0 | 0.30 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 118 / 15264 (0.8%) | 5481 / 152640 (3.6%) | −104.8 | −102.9 | 0.22 |
| NKX2-1 SRX2164786 | A549 Lung | 657 / 15264 (4.3%) | 13862 / 152640 (9.1%) | −104.6 | −102.7 | 0.47 |
| ZFX SRX7805370 | 293 Kidney | 938 / 15264 (6.1%) | 4014 / 152640 (2.6%) | −104.5 | −102.5 | 2.34 |
| INTS3 SRX3640569 | HeLa Uterus | 1044 / 15264 (6.8%) | 4715 / 152640 (3.1%) | −104.4 | −102.5 | 2.21 |
| FOXA3 SRX2630190 | Hep G2 Liver | 344 / 15264 (2.3%) | 9303 / 152640 (6.1%) | −104.4 | −102.4 | 0.37 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 328 / 15264 (2.1%) | 9053 / 152640 (5.9%) | −104.3 | −102.4 | 0.36 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 709 / 15264 (4.6%) | 2589 / 152640 (1.7%) | −104.1 | −102.2 | 2.74 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 340 / 15264 (2.2%) | 9221 / 152640 (6.0%) | −103.8 | −101.9 | 0.37 |
| ESR1 SRX5534831 | MCF-7 Breast | 317 / 15264 (2.1%) | 8859 / 152640 (5.8%) | −103.8 | −101.9 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 251 / 15264 (1.6%) | 7801 / 152640 (5.1%) | −103.8 | −101.8 | 0.32 |
| KMT2C SRX1787675 | MCF-7 Breast | 359 / 15264 (2.4%) | 9500 / 152640 (6.2%) | −103.4 | −101.5 | 0.38 |
| ESR1 SRX5323877 | MCF-7 Breast | 322 / 15264 (2.1%) | 8920 / 152640 (5.8%) | −103.3 | −101.4 | 0.36 |
| KMT2A SRX2281249 | SEM Blood | 1591 / 15264 (10.4%) | 8642 / 152640 (5.7%) | −103.2 | −101.2 | 1.84 |
| FOXA1 SRX3923515 | MCF-7 Breast | 231 / 15264 (1.5%) | 7444 / 152640 (4.9%) | −103.1 | −101.2 | 0.31 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 462 / 15264 (3.0%) | 1245 / 152640 (0.8%) | −102.8 | −100.9 | 3.71 |
| FOXA1 SRX5323830 | T-47D Breast | 245 / 15264 (1.6%) | 7661 / 152640 (5.0%) | −102.7 | −100.8 | 0.32 |
| ESR1 SRX1469951 | MCF-7 Breast | 218 / 15264 (1.4%) | 7210 / 152640 (4.7%) | −102.7 | −100.8 | 0.30 |
| FOXA1 SRX3931033 | MCF-7 Breast | 261 / 15264 (1.7%) | 7924 / 152640 (5.2%) | −102.7 | −100.7 | 0.33 |
| SREBF2 SRX5359049 | HCC70 Breast | 974 / 15264 (6.4%) | 4288 / 152640 (2.8%) | −102.6 | −100.7 | 2.27 |
| VGLL1 SRX24602130 | BT-20 Breast | 443 / 15264 (2.9%) | 10728 / 152640 (7.0%) | −102.6 | −100.7 | 0.41 |
| STAT3 SRX150479 | MCF 10A Breast | 395 / 15264 (2.6%) | 10010 / 152640 (6.6%) | −102.5 | −100.6 | 0.39 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 841 / 15264 (5.5%) | 16254 / 152640 (10.6%) | −102.4 | −100.5 | 0.52 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1310 / 15264 (8.6%) | 6609 / 152640 (4.3%) | −102.3 | −100.4 | 1.98 |
| EP300 SRX1012643 | MCF-7 Breast | 157 / 15264 (1.0%) | 6135 / 152640 (4.0%) | −102.3 | −100.4 | 0.26 |
| EP300 SRX100544 | Hep G2 Liver | 318 / 15264 (2.1%) | 8818 / 152640 (5.8%) | −102.2 | −100.3 | 0.36 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 998 / 15264 (6.5%) | 4456 / 152640 (2.9%) | −102.2 | −100.3 | 2.24 |
| FOXA1 SRX6860635 | T-47D Breast | 308 / 15264 (2.0%) | 8657 / 152640 (5.7%) | −102.1 | −100.2 | 0.36 |
| NFIL3 SRX2630334 | Hep G2 Liver | 334 / 15264 (2.2%) | 9062 / 152640 (5.9%) | −102.0 | −100.1 | 0.37 |
| CHD6 SRX17709201 | C4-2 Prostate | 1248 / 15264 (8.2%) | 6186 / 152640 (4.1%) | −101.6 | −99.7 | 2.02 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 392 / 15264 (2.6%) | 9925 / 152640 (6.5%) | −101.5 | −99.6 | 0.39 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 580 / 15264 (3.8%) | 12654 / 152640 (8.3%) | −101.4 | −99.5 | 0.46 |
| STAT3 SRX150536 | MCF 10A Breast | 470 / 15264 (3.1%) | 11065 / 152640 (7.2%) | −101.1 | −99.2 | 0.42 |
| FOXA1 SRX9604645 | LNCAP Prostate | 565 / 15264 (3.7%) | 12428 / 152640 (8.1%) | −101.0 | −99.1 | 0.45 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 778 / 15264 (5.1%) | 15347 / 152640 (10.1%) | −101.0 | −99.1 | 0.51 |
| FOXA1 SRX3923519 | MCF-7 Breast | 256 / 15264 (1.7%) | 7779 / 152640 (5.1%) | −100.9 | −99.0 | 0.33 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1009 / 15264 (6.6%) | 4560 / 152640 (3.0%) | −100.7 | −98.8 | 2.21 |
| FOXA1 SRX2642368 | VCaP Prostate | 495 / 15264 (3.2%) | 11411 / 152640 (7.5%) | −100.7 | −98.8 | 0.43 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1865 / 15264 (12.2%) | 10806 / 152640 (7.1%) | −100.5 | −98.6 | 1.73 |
| WWTR1 SRX10119367 | MCF 10A Breast | 489 / 15264 (3.2%) | 11315 / 152640 (7.4%) | −100.4 | −98.5 | 0.43 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 941 / 15264 (6.2%) | 17469 / 152640 (11.4%) | −100.3 | −98.4 | 0.54 |
| TFAP2C SRX128099 | MCF-7 Breast | 369 / 15264 (2.4%) | 9529 / 152640 (6.2%) | −100.2 | −98.3 | 0.39 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 464 / 15264 (3.0%) | 1283 / 152640 (0.8%) | −100.2 | −98.3 | 3.62 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 233 / 15264 (1.5%) | 292 / 152640 (0.2%) | −100.1 | −98.2 | 7.98 |
| FOS SRX3322636 | MCF-7 Breast | 287 / 15264 (1.9%) | 8248 / 152640 (5.4%) | −100.0 | −98.1 | 0.35 |
| ESR1 SRX2513517 | MCF-7 Breast | 292 / 15264 (1.9%) | 8328 / 152640 (5.5%) | −100.0 | −98.1 | 0.35 |
| ESR1 SRX2912055 | MCF-7 Breast | 173 / 15264 (1.1%) | 6342 / 152640 (4.2%) | −99.8 | −97.9 | 0.27 |
| ARID5B SRX10475138 | Hep G2 Liver | 676 / 15264 (4.4%) | 13916 / 152640 (9.1%) | −99.8 | −97.9 | 0.49 |
| FOXA1 SRX190181 | A549 Lung | 307 / 15264 (2.0%) | 8557 / 152640 (5.6%) | −99.8 | −97.9 | 0.36 |
| KAT6A DRX366108 | 293 Kidney | 1401 / 15264 (9.2%) | 7335 / 152640 (4.8%) | −99.8 | −97.9 | 1.91 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 381 / 15264 (2.5%) | 9694 / 152640 (6.4%) | −99.7 | −97.8 | 0.39 |
| FOXA1 SRX13814018 | 5637 Others | 273 / 15264 (1.8%) | 8013 / 152640 (5.2%) | −99.7 | −97.8 | 0.34 |
| SMARCA4 SRX5212366 | Mel270 Others | 559 / 15264 (3.7%) | 12283 / 152640 (8.0%) | −99.7 | −97.8 | 0.46 |
| EP300 SRX150579 | HeLa Uterus | 297 / 15264 (1.9%) | 8398 / 152640 (5.5%) | −99.7 | −97.8 | 0.35 |
| ESR1 SRX2513520 | MCF-7 Breast | 270 / 15264 (1.8%) | 7962 / 152640 (5.2%) | −99.6 | −97.7 | 0.34 |
| CEBPB SRX2194250 | SUM 159PT Breast | 513 / 15264 (3.4%) | 11625 / 152640 (7.6%) | −99.6 | −97.7 | 0.44 |
| MEN1 SRX11712604 | K-562 Blood | 1143 / 15264 (7.5%) | 5502 / 152640 (3.6%) | −99.5 | −97.6 | 2.08 |
| TFAP2C SRX018833 | MCF-7 Breast | 371 / 15264 (2.4%) | 9533 / 152640 (6.2%) | −99.5 | −97.6 | 0.39 |
| FOXA1 SRX1161205 | T-47D Breast | 229 / 15264 (1.5%) | 7284 / 152640 (4.8%) | −99.3 | −97.5 | 0.31 |
| ESR1 SRX2513521 | MCF-7 Breast | 209 / 15264 (1.4%) | 6949 / 152640 (4.6%) | −99.3 | −97.5 | 0.30 |
| NR3C1 SRX19024866 | MCF-7 Breast | 157 / 15264 (1.0%) | 6032 / 152640 (4.0%) | −99.1 | −97.3 | 0.26 |
| STAT3 SRX150630 | MCF 10A Breast | 400 / 15264 (2.6%) | 9956 / 152640 (6.5%) | −99.1 | −97.2 | 0.40 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 406 / 15264 (2.7%) | 10042 / 152640 (6.6%) | −99.0 | −97.1 | 0.40 |
| ESR1 SRX11120903 | MCF-7 Breast | 367 / 15264 (2.4%) | 9451 / 152640 (6.2%) | −98.9 | −97.1 | 0.39 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1366 / 15264 (8.9%) | 7102 / 152640 (4.7%) | −98.9 | −97.0 | 1.92 |
| ESR1 SRX5323874 | MCF-7 Breast | 255 / 15264 (1.7%) | 7689 / 152640 (5.0%) | −98.7 | −96.9 | 0.33 |
| SMARCA4 SRX5212362 | Mel270 Others | 707 / 15264 (4.6%) | 14289 / 152640 (9.4%) | −98.7 | −96.8 | 0.49 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 285 / 15264 (1.9%) | 8169 / 152640 (5.4%) | −98.7 | −96.8 | 0.35 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 264 / 15264 (1.7%) | 7833 / 152640 (5.1%) | −98.6 | −96.7 | 0.34 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 486 / 15264 (3.2%) | 11197 / 152640 (7.3%) | −98.5 | −96.6 | 0.43 |
| ETS1 SRX3033231 | HEYA8 Gonad | 234 / 15264 (1.5%) | 303 / 152640 (0.2%) | −98.4 | −96.6 | 7.72 |
| CHD6 SRX17709200 | C4-2 Prostate | 1274 / 15264 (8.3%) | 6453 / 152640 (4.2%) | −98.4 | −96.5 | 1.97 |
| SMARCA4 SRX5212357 | Mel270 Others | 601 / 15264 (3.9%) | 12819 / 152640 (8.4%) | −98.3 | −96.5 | 0.47 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 131 / 15264 (0.9%) | 5526 / 152640 (3.6%) | −98.2 | −96.3 | 0.24 |
| TCF12 SRX190356 | SK-N-SH Neural | 1066 / 15264 (7.0%) | 18975 / 152640 (12.4%) | −98.1 | −96.3 | 0.56 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 218 / 15264 (1.4%) | 7058 / 152640 (4.6%) | −98.1 | −96.3 | 0.31 |
| NR3C1 SRX8520802 | HCC1187 Breast | 323 / 15264 (2.1%) | 8739 / 152640 (5.7%) | −97.8 | −96.0 | 0.37 |
| RXRB SRX2636027 | Hep G2 Liver | 454 / 15264 (3.0%) | 10706 / 152640 (7.0%) | −97.8 | −96.0 | 0.42 |
| ESR1 SRX2881001 | MCF-7 Breast | 239 / 15264 (1.6%) | 7394 / 152640 (4.8%) | −97.8 | −95.9 | 0.32 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1238 / 15264 (8.1%) | 21122 / 152640 (13.8%) | −97.7 | −95.8 | 0.59 |
| FOXA1 SRX3931056 | MCF-7 Breast | 252 / 15264 (1.7%) | 7603 / 152640 (5.0%) | −97.7 | −95.8 | 0.33 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1435 / 15264 (9.4%) | 7652 / 152640 (5.0%) | −97.4 | −95.5 | 1.88 |
| CDK9 SRX20230574 | Ishikawa Uterus | 1215 / 15264 (8.0%) | 6058 / 152640 (4.0%) | −97.4 | −95.5 | 2.01 |
| FOXA1 SRX6878604 | LNCAP Prostate | 342 / 15264 (2.2%) | 9012 / 152640 (5.9%) | −97.3 | −95.5 | 0.38 |
| FOXA1 SRX5203303 | MCF-7 Breast | 154 / 15264 (1.0%) | 5920 / 152640 (3.9%) | −97.3 | −95.4 | 0.26 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 284 / 15264 (1.9%) | 8102 / 152640 (5.3%) | −97.2 | −95.4 | 0.35 |
| JUND SRX150408 | HeLa Uterus | 388 / 15264 (2.5%) | 9702 / 152640 (6.4%) | −97.2 | −95.4 | 0.40 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 1035 / 15264 (6.8%) | 4810 / 152640 (3.2%) | −97.2 | −95.3 | 2.15 |
| Epitope tags SRX10549777 | K-562 Blood | 1994 / 15264 (13.1%) | 11940 / 152640 (7.8%) | −97.0 | −95.1 | 1.67 |
| CBX3 SRX6712570 | MCF-7 Breast | 344 / 15264 (2.3%) | 9024 / 152640 (5.9%) | −96.8 | −95.0 | 0.38 |
| AFF1 SRX2281250 | SEM Blood | 776 / 15264 (5.1%) | 3122 / 152640 (2.0%) | −96.8 | −95.0 | 2.49 |
| JUNB SRX10119384 | MCF 10A Breast | 276 / 15264 (1.8%) | 7959 / 152640 (5.2%) | −96.8 | −94.9 | 0.35 |
| ESR1 SRX1012628 | MCF-7 Breast | 228 / 15264 (1.5%) | 7173 / 152640 (4.7%) | −96.7 | −94.8 | 0.32 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 376 / 15264 (2.5%) | 890 / 152640 (0.6%) | −96.5 | −94.7 | 4.22 |
| ESR1 SRX4451214 | MCF-7 Breast | 381 / 15264 (2.5%) | 9571 / 152640 (6.3%) | −96.5 | −94.6 | 0.40 |
| AR SRX9468664 | LNCAP Prostate | 576 / 15264 (3.8%) | 12386 / 152640 (8.1%) | −96.5 | −94.6 | 0.47 |
| FOXA1 SRX1161207 | T-47D Breast | 182 / 15264 (1.2%) | 6388 / 152640 (4.2%) | −96.4 | −94.6 | 0.28 |
| PHF6 SRX11508321 | G-401 Kidney | 1241 / 15264 (8.1%) | 6274 / 152640 (4.1%) | −96.2 | −94.4 | 1.98 |
| FOXA1 SRX1161172 | MCF-7 Breast | 421 / 15264 (2.8%) | 10154 / 152640 (6.7%) | −96.2 | −94.3 | 0.41 |
| ESR1 SRX371446 | Tumour tissues Others | 437 / 15264 (2.9%) | 10385 / 152640 (6.8%) | −96.1 | −94.3 | 0.42 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 109 / 15264 (0.7%) | 5048 / 152640 (3.3%) | −96.1 | −94.2 | 0.22 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 285 / 15264 (1.9%) | 8075 / 152640 (5.3%) | −96.1 | −94.2 | 0.35 |
| VGLL1 SRX18013277 | FULVR Breast | 201 / 15264 (1.3%) | 6697 / 152640 (4.4%) | −95.9 | −94.0 | 0.30 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 501 / 15264 (3.3%) | 11300 / 152640 (7.4%) | −95.8 | −94.0 | 0.44 |
| FOXA1 SRX497612 | VCaP Prostate | 401 / 15264 (2.6%) | 9838 / 152640 (6.4%) | −95.7 | −93.8 | 0.41 |
| FOXA1 SRX3931032 | MCF-7 Breast | 254 / 15264 (1.7%) | 7567 / 152640 (5.0%) | −95.7 | −93.8 | 0.34 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 431 / 15264 (2.8%) | 10279 / 152640 (6.7%) | −95.7 | −93.8 | 0.42 |
| NR3C1 SRX17639413 | A549 Lung | 306 / 15264 (2.0%) | 8391 / 152640 (5.5%) | −95.6 | −93.8 | 0.36 |
| RELA SRX5938177 | FaDu Others | 410 / 15264 (2.7%) | 9966 / 152640 (6.5%) | −95.6 | −93.8 | 0.41 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 145 / 15264 (0.9%) | 72 / 152640 (0.0%) | −95.6 | −93.7 | 20.14 |
| STAT1 SRX23678708 | K-562 Blood | 1219 / 15264 (8.0%) | 6135 / 152640 (4.0%) | −95.5 | −93.7 | 1.99 |
| ESR1 SRX330068 | MCF-7 Breast | 214 / 15264 (1.4%) | 6898 / 152640 (4.5%) | −95.4 | −93.5 | 0.31 |
| ESR1 SRX3110723 | MCF-7 Breast | 244 / 15264 (1.6%) | 7387 / 152640 (4.8%) | −95.1 | −93.3 | 0.33 |
| NCOA3 SRX4663589 | MCF-7 Breast | 129 / 15264 (0.8%) | 5396 / 152640 (3.5%) | −95.1 | −93.2 | 0.24 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 334 / 15264 (2.2%) | 8802 / 152640 (5.8%) | −95.0 | −93.1 | 0.38 |
| FOXA1 SRX2017929 | LNCAP Prostate | 543 / 15264 (3.6%) | 11857 / 152640 (7.8%) | −94.9 | −93.1 | 0.46 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 724 / 15264 (4.7%) | 14344 / 152640 (9.4%) | −94.8 | −93.0 | 0.50 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1292 / 15264 (8.5%) | 6678 / 152640 (4.4%) | −94.8 | −93.0 | 1.93 |
| FOXA1 SRX3923511 | MCF-7 Breast | 171 / 15264 (1.1%) | 6145 / 152640 (4.0%) | −94.8 | −93.0 | 0.28 |
| FOXA1 SRX1961163 | T-47D Breast | 279 / 15264 (1.8%) | 7936 / 152640 (5.2%) | −94.8 | −93.0 | 0.35 |
| FOXA1 SRX5323845 | MCF-7 Breast | 166 / 15264 (1.1%) | 6048 / 152640 (4.0%) | −94.6 | −92.8 | 0.27 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1454 / 15264 (9.5%) | 7880 / 152640 (5.2%) | −94.4 | −92.5 | 1.85 |
| JUNB SRX10119383 | MCF 10A Breast | 311 / 15264 (2.0%) | 8421 / 152640 (5.5%) | −94.4 | −92.5 | 0.37 |
Showing first 500 of 26941 rows.